Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenibArticle Published on 2017-07-012023-06-19 Journal: Cytokine [Category] B형 간염, [키워드] Fibroblast growth factor-2 Hepatocellular carcinoma interleukin-17A Prognosis sorafenib [DOI] 10.1016/j.cyto.2017.02.020
Lactate dehydrogenase is a prognostic indicator in patients with hepatocellular carcinoma treated by sorafenib: results from the real life practice in HBV endemic areaResearch Paper Published on 2016-12-272023-06-02 Journal: Oncotarget [Category] B형 간염, [키워드] HBV endemic area Hepatocellular carcinoma LDH Prognosis sorafenib [DOI] 10.18632/oncotarget.13428 PMC 바로가기 [Article Type] Research Paper
Cost-effectiveness analysis of antiviral therapy in patients with advanced hepatitis B virus-related hepatocellular carcinoma treated with sorafenibComparative Study Published on 2016-12-012023-06-16 Journal: Journal of gastroenterology and hepatology [Category] B형 간염, [키워드] antiviral therapy cost-effectiveness Hepatitis B virus Hepatocellular carcinoma sorafenib [DOI] 10.1111/jgh.13425 [Article Type] Comparative Study
Hepatocellular carcinoma cases with high levels of c-Raf-1 expression may benefit from postoperative adjuvant sorafenib after hepatic resection even with high risk of recurrenceResearch Paper Published on 2016-07-052023-06-02 Journal: Oncotarget [Category] B형 간염, [키워드] Hepatocellular carcinoma Liver resection recurrence Risk factors sorafenib [DOI] 10.18632/oncotarget.3799 PMC 바로가기 [Article Type] Research Paper